Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy.

Toshifumi TadaT KumadaH ToyodaY SoneK TakeshimaS OgawaT GotoA WakahataM NakashimaM NakamutaJ Tanaka

Published in: Alimentary pharmacology & therapeutics (2018)

Viral eradication reduces both liver stiffness and steatosis in patients with chronic HCV who received direct-acting anti-viral therapy (UMIN000017020).

Keyphrases

sars cov
hepatitis c virus infection
insulin resistance
high fat diet
hepatitis c virus
helicobacter pylori infection
human immunodeficiency virus
helicobacter pylori